Newly documented antimicrobial activity of quinolones (Q37222571)

19 August 2017

1 reference

title

Newly documented antimicrobial activity of quinolones (English)

1 reference

19 August 2017

0 references

Y. X. Furet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1864284

12 December 2022

J. C. Pechère

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1864284

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1864284

12 December 2022

publication date

1 April 1991

1 reference

full work available at URL

19 August 2017

http://link.springer.com/content/pdf/10.1007/BF01966997.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01966997/fulltext.html

12 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF01966997

12 December 2022

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

12 December 2022

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

249-254

1 reference

In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone

19 August 2017

cites work

1 reference

In vitro activity of AT-4140 against clinical bacterial isolates

21 January 2018

1 reference

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

21 January 2018

1 reference

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

21 January 2018

1 reference

In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone

21 January 2018

1 reference

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

21 January 2018

1 reference

Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species

21 January 2018

1 reference

Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria

21 January 2018

1 reference

Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess

21 January 2018

1 reference

Mycobacteria and the new quinolones

21 January 2018

1 reference

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

21 January 2018

1 reference

Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents

21 January 2018

1 reference

Influence of N substitution on antimycobacterial activity of ciprofloxacin

21 January 2018

1 reference

Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae

21 January 2018

1 reference

WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages

21 January 2018

1 reference

Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method

21 January 2018

1 reference

Ciprofloxacin therapy for Mediterranean spotted fever

21 January 2018

1 reference

Efficacy of ciprofloxacin against Leptospira interrogans serogroup icterohaemorrhagiae

21 January 2018

1 reference

Norfloxacin: a new drug in the treatment of falciparum malaria

21 January 2018

1 reference

Fluoroquinolones for malaria: the newest kid on the block?

21 January 2018

1 reference

Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium

21 January 2018

1 reference

[Therapeutic effect of ofloxacin (DL 8280) on pulmonary tuberculosis. (Report of a one year-administration study on sixteen treatment-failure patients)]

21 January 2018

1 reference

12 December 2020

In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria

1 reference

12 December 2020

Treatment of experimental Salmonella typhimurium infection in mice with lomefloxacin

1 reference

12 December 2020

Ciprofloxacin and malaria

1 reference

12 December 2020

The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes

1 reference

12 December 2020

Comparative chemotherapeutic activity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model.

1 reference

12 December 2020

Potent antibacterial fluoroquinolones with marked activity against Leishmania donovani in vivo

1 reference

12 December 2020

Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage

1 reference

12 December 2020

In-vitro activity of ciprofloxacin and other agents against oral bacteria

1 reference

12 December 2020

Quinolones and multiresistant Plasmodium falciparum

1 reference

12 December 2020

In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid

1 reference

12 December 2020

In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients

1 reference

12 December 2020

Activity of ofloxacin against Mycobacterium leprae in the mouse

1 reference

12 December 2020

The in-vitro activity of PD127,391, a new quinolone

1 reference

12 December 2020

Activities of pefloxacin and ciprofloxacin against Mycobacterium leprae in the mouse

1 reference

12 December 2020

Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro

1 reference

12 December 2020

In vitro susceptibility of selected veterinary bacterial pathogens to ciprofloxacin, enrofloxacin and norfloxacin

1 reference

12 December 2020

In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice

1 reference

12 December 2020

Laboratory survey of fluoroquinolone activity

1 reference

12 December 2020

Comparative in-vitro activity of twenty antimicrobial agents against clinical isolates of Mycobacterium avium complex

1 reference

12 December 2020

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

1 reference

12 December 2020

The killing action of fleroxacin upon Bacteroides fragilis

1 reference

12 December 2020

The antimalarial activity of some quinolone esters

1 reference

12 December 2020

International Journal of Leprosy

21

55

70

CC Guelpa-Lauras

1987

1 reference

International Journal of Leprosy

12 December 2022

22

50

259

JH Grosset

1988

1 reference

Reviews of Infectious Diseases

12 December 2022

29

11

989

E Bernard

1989

1 reference

Reviews of Infectious Diseases

12 December 2022

30

11

991

F Janbon

1989

1 reference

Canadian Journal of Veterinary Research

12 December 2022

34

54

195

JF Prescott

1990

1 reference

12 December 2022

Medical science research

45

16

141

D Betbeder

1988

1 reference

12 December 2022

Identifiers

DOI

10.1007/BF01966997

1 reference

19 August 2017

1 reference